Ossium supports customers from discovery through commercialization by supplying both clinical and research grade human cells. We provide bone marrow derived human CD34+ cells and mesenchymal stem cells (MSCs) produced at our GMP facility, access to our product master files, optional white-labeling, and regulatory support. We’ve invested in building a state-of-the-art production facility, a team with deep CMC expertise, and comprehensive donor qualification capabilities so that you can focus on your research goals.
Ossium Inventa products are currently used in several IND’s. Ossium Inventa can deliver their product across the globe with very little turnaround time (few day small order <100M cells up to max 2-4 week >100M cells). All Ossium cell products is delivered at P2 or P4 and we can provide you with unmatched high volume of total cells from the same single donor without ever exceeding P4.